Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Switching to Sulfonylurea in MODY
NCT04239586Phase 4Unknown
- Sponsor
- Haukeland University Hospital
- Start
- Apr 2017
- Primary completion
- Apr 2022
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial in Maturity Onset Diabetes of the Young (MODY), sponsored by Haukeland University Hospital. Primary endpoints: Effect of sulfonylurea treatment on insulin requirement at 5 years and Metabolic control of diabetes measured by HbA1c at 5 years. Status: unknown.
02
Conditions
Maturity Onset Diabetes of the Young (MODY)
Beyond the preview
Go deeper on NCT04239586.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04239586.